DK1446425T3 - Behandling af infektioner forårsaget af mikroorganismer - Google Patents

Behandling af infektioner forårsaget af mikroorganismer

Info

Publication number
DK1446425T3
DK1446425T3 DK02777534T DK02777534T DK1446425T3 DK 1446425 T3 DK1446425 T3 DK 1446425T3 DK 02777534 T DK02777534 T DK 02777534T DK 02777534 T DK02777534 T DK 02777534T DK 1446425 T3 DK1446425 T3 DK 1446425T3
Authority
DK
Denmark
Prior art keywords
microorganisms
treatment
infections caused
antibody
daptomycin
Prior art date
Application number
DK02777534T
Other languages
English (en)
Inventor
James Peter Burnie
Ruth Christine Matthews
Original Assignee
Neutec Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Ltd filed Critical Neutec Pharma Ltd
Application granted granted Critical
Publication of DK1446425T3 publication Critical patent/DK1446425T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK02777534T 2001-11-22 2002-11-13 Behandling af infektioner forårsaget af mikroorganismer DK1446425T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0127983.5A GB0127983D0 (en) 2001-11-22 2001-11-22 Treatment of micro-organism infection
PCT/GB2002/005135 WO2003046007A2 (en) 2001-11-22 2002-11-13 Treatment of micro-organism infection

Publications (1)

Publication Number Publication Date
DK1446425T3 true DK1446425T3 (da) 2009-07-20

Family

ID=9926237

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02777534T DK1446425T3 (da) 2001-11-22 2002-11-13 Behandling af infektioner forårsaget af mikroorganismer

Country Status (18)

Country Link
US (3) US20050118162A1 (da)
EP (2) EP1964851A1 (da)
JP (1) JP2005511645A (da)
CN (2) CN101254304A (da)
AT (1) ATE427320T1 (da)
AU (2) AU2002339159B2 (da)
BR (1) BR0214363A (da)
CA (1) CA2465072A1 (da)
DE (1) DE60231825D1 (da)
DK (1) DK1446425T3 (da)
ES (1) ES2322756T3 (da)
GB (1) GB0127983D0 (da)
NO (2) NO20042604L (da)
NZ (1) NZ533623A (da)
PL (1) PL369536A1 (da)
PT (1) PT1446425E (da)
RU (1) RU2303460C2 (da)
WO (1) WO2003046007A2 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127983D0 (en) * 2001-11-22 2002-01-16 Neutec Pharma Plc Treatment of micro-organism infection
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
JP5248032B2 (ja) * 2007-04-23 2013-07-31 株式会社Ａｄｅｋａ ケイ素含有化合物、硬化性組成物及び硬化物
JP5248033B2 (ja) * 2007-04-23 2013-07-31 株式会社Ａｄｅｋａ ケイ素含有化合物、硬化性組成物及び硬化物
WO2008132174A1 (en) * 2007-04-27 2008-11-06 Novartis Ag An immunoglobulin composition
US20100113355A1 (en) 2007-04-27 2010-05-06 Naresh Chennamsetty Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
CN102695724B (zh) * 2009-05-18 2016-08-24 维尔茨堡尤利乌斯·马克西米利安大学 指向金黄葡萄球菌表位isaa或isab的抗体或其片段
US20110020323A1 (en) * 2009-07-15 2011-01-27 Tim Beaumont Gram-positive bacteria specific binding compounds
US9005579B2 (en) * 2010-01-05 2015-04-14 Contrafect Corporation Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
US20120271272A1 (en) 2010-10-15 2012-10-25 Iscience Interventional Corporation Device for ocular access
AU2011317021B2 (en) * 2010-10-20 2015-07-09 Medimmune, Llc Methods for processing inclusion bodies
US9539139B2 (en) 2013-05-03 2017-01-10 Clearside Biomedical, Inc. Apparatus and methods for ocular injection
RU2572341C2 (ru) * 2013-09-20 2016-01-10 Федеральное государственное бюджетное учреждение Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе Российской академии медицинских наук (ФГБУ "НИИНА" РАМН) АНТИБИОТИК ИНА 5812, ШТАММ-ПРОДУЦЕНТ Streptomyces roseoflavus ИНА-Ас-5812 И СПОСОБ ПОЛУЧЕНИЯ АНТИБИОТИКА
CA3062845A1 (en) 2016-05-02 2017-11-09 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
CA3072847A1 (en) 2016-08-12 2018-02-15 Clearside Biomedical, Inc. Devices and methods for adjusting the insertion depth of a needle for medicament delivery
US12090294B2 (en) 2017-05-02 2024-09-17 Georgia Tech Research Corporation Targeted drug delivery methods using a microneedle

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
NZ291659A (en) * 1994-09-06 2001-04-27 Galagen Inc Use in the manufacture of a medicament of an antibody having specific activity against Clostridium difficile, and pharmaceutical compositions comprising Anti-Clostridium difficile bovine immunoglobulin concentrate; for treating diseases associated with Clostridium difficile
GB9614274D0 (en) * 1996-07-06 1996-09-04 Univ Manchester Treatment and diagnosis of infections of gram positive cocci
GB9806762D0 (en) * 1998-03-31 1998-05-27 Neutec Pharma Plc Treatment and diagnosis of staphylococcal infections
GB0127983D0 (en) * 2001-11-22 2002-01-16 Neutec Pharma Plc Treatment of micro-organism infection

Also Published As

Publication number Publication date
AU2002339159B2 (en) 2008-06-05
AU2002339159A1 (en) 2003-06-10
NO20081575L (no) 2004-06-21
ATE427320T1 (de) 2009-04-15
PT1446425E (pt) 2009-07-01
US20050118162A1 (en) 2005-06-02
NZ533623A (en) 2005-12-23
CN101254304A (zh) 2008-09-03
RU2303460C2 (ru) 2007-07-27
EP1964851A1 (en) 2008-09-03
WO2003046007A3 (en) 2004-03-11
ES2322756T3 (es) 2009-06-26
NO20042604L (no) 2004-06-21
DE60231825D1 (de) 2009-05-14
PL369536A1 (en) 2005-05-02
EP1446425A2 (en) 2004-08-18
GB0127983D0 (en) 2002-01-16
BR0214363A (pt) 2004-10-26
RU2004118716A (ru) 2005-03-27
AU2008212001A1 (en) 2008-09-25
WO2003046007A2 (en) 2003-06-05
EP1446425B1 (en) 2009-04-01
CN100371348C (zh) 2008-02-27
US20070202116A1 (en) 2007-08-30
CA2465072A1 (en) 2003-06-05
JP2005511645A (ja) 2005-04-28
US20080171054A1 (en) 2008-07-17
CN1589280A (zh) 2005-03-02

Similar Documents

Publication Publication Date Title
NO20081575L (no) Behandling av mikroorganismeinfeksjoner
CY1112833T1 (el) Καινοφανης προσδετης της κυτοκινης ζcυτοr17
BR0209434A (pt) Peptìdeos antimicrobianos e composições
ATE263778T1 (de) Niedrigallergene proteinvarianten
RS51635B (sr) Antitela koja blokiraju cripto i njihova upotreba
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
DK1644504T3 (da) Faktor VII- eller -VIIA-Gla-domænevarianter
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
DE60228136D1 (de) Cytokin-proteinfamilie
DK1368372T3 (da) Peptid med affinitet til det virale gp120-protein samt anvendelse deraf
NZ591827A (en) Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating immune reaction in a radiotherapy-induced immuno-compromised subject
WO2002085934A3 (fr) Peptides antibacteriens, les compositions les contenant et leurs utilisations
ATE441713T1 (de) Tumorantigenprotein und dessen verwendung
BRPI0417798A (pt) proteìna de membrana externa de 72 kda de brachyspira pilosicoli e usos diagnósticos e terapêuticos da mesma
WO2001058471A3 (en) Novel amino acid and peptide inhibitors of staphylococcus virulence
WO2003027274A3 (en) Purified polypeptides from pseudomonas aeruginosa
WO2003089472A3 (en) Anti-nls scfv and peptides and uses thereof in nuclear import inhibition
CO4820441A1 (es) Antigeno bm 95 de la garrapata boophilus microplus, aislamiento, secuencia, adn recombinantes, microorganismos transformados y preparacion vacunal
ATE346862T1 (de) Aus pflanzen gewonnene peptide mit wasserreinigender und antimikrobieller wirkung
WO2004058811A3 (en) Crystal structures of yhhf polypeptides
WO2004041856A3 (en) Crystal structures of bacterial inorganic pyrophosphatases
WO2003029290A1 (fr) Transporteur de medicament et son utilisation
ATE394364T1 (de) Reinigungsverfahren von n-(1(s)-ethoxycarbonyl-3- phenylpropyl)-l-alanin
WO2003055904A3 (en) Peptidyl-trna hydrolase from pseudomonas aeruginosa
WO2004042044A3 (en) Crystal structures of bacterial guanylate kinases